Breaks Categories: News

TuesdayOct 12, 2021 10:51 am

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Subsidiary Receives Cannabis Cultivation License, Commences Grow Operations

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, announced that its subsidiary, Red White & Bloom Florida LLC, has received approval to begin growth operations at its 45,000-square-foot greenhouse in Apopka, Florida. The company has completed phase one of its cultivation strategy and is in the midst of a three-phase development plan for two Florida cultivation centers. The centers are part RWBYF’s plan to produce adequate inventory for existing and new dispensary openings planned for Q1 2022. The company had plants at the greenhouse ready to plant as soon as approval…

Continue Reading

ThursdayOct 07, 2021 2:32 pm

CannabisNewsBreaks – Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) Announces Entry into Strategic LOI

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) today announced its entry into a letter of intent (“LOI”) for the formation of a commercial relationship with Kingston Cannabis Inc. (“KCI”), a Health Canada licensed producer, to launch its cannabis-infused beverages through a co-packing arrangement with KCI. Under the arrangement, KCI’s affiliate, Kingston Aluminum Technologies Inc. (“KAT”) will provide custom designed aluminum packaging for Sproutly’s products. In addition, KCI and Sproutly will collaborate on the consumer evaluation of Sproutly’s formulations made using ingredients produced by the proprietary APP cannabis processing technology. “This relationship will allow us to launch our beverages made…

Continue Reading

ThursdayOct 07, 2021 10:40 am

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Enters Strategic Agreement to Produce Cannabis-Infused Beverages for Xebra Brands

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, today announced its entry into a white-label agreement with Xebra Brands Ltd., a rising player in the global cannabis beverage sector. Under the agreement, BevCanna will leverage its extensive experience in production and manufacturing at scale to distribute Xebra Brands’ Vicious Citrus(TM) THC Lemonade into the Canadian market. Selected as Xebra’s premier beverage to launch in Canada through consultation with provincial sales representatives, Vicious Citrus was noted as unique among cannabis beverages offered in Canada. Initially set to premiere in Spring…

Continue Reading

WednesdayOct 06, 2021 11:59 am

CannabisNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Alkaline88 Available in Sam’s Club This Fall

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company, has announced that Sam’s Club will carry its Alkaline88(R) single-serve, one-Liter 12-pack offering in all 587 locations in the continental U.S. The product will be available by early November. The company stated that the agreement was possible because of its increased supply chain and production capabilities, including four new co-packers working to support WTER’s expected increase in volume. The single-serve, one-liter is the first of WTER’s products available in the all-important club channel, but the company hopes more of its offerings will follow. A leading membership…

Continue Reading

WednesdayOct 06, 2021 10:34 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Launch of Global Clinical Trials

Flora Growth Corp. (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has announced its entry into an agreement to begin scientific clinical trials globally. According to the update, the focus of this study will be on the use of cannabinoids in patients suffering from fibromyalgia or chronic pain, with primary research sites located in the United States and the United Kingdom. By running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.), Flora Pharma expects to fast track traditional FDA and NHS timelines. “A paradigm shift is upon us where…

Continue Reading

TuesdayOct 05, 2021 1:46 pm

CannabisNewsBreaks – Cannabis Strategic Ventures (NUGS) Launches LA Dispensary Brand, Announces Cultivation Expansion

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, is beginning to deploy its licenses; that process includes the opening of the first Los Angeles location of MDRN (“MDRN”) Tree, the company’s customer-facing dispensary brand. After the opening of its LA location, NUBS anticipates utilizing another of its new licenses to establish an indoor cultivation facility. With up to 1,200 grow lights, the facility is expected to product two to three pounds of premium exotic cannabis flower per light per harvest, with the company projected an average of 5.75 harvests per year. Based on that production,…

Continue Reading

TuesdayOct 05, 2021 1:24 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Outstanding Results of Oral Nicotine Study

Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its recent oral nicotine absorption study NIC-A21-1 revealed that DehydraTECH(TM)-nicotine delivered via the oral pouch product format required only two to four minutes to deliver nicotine levels in blood plasma comparable to levels achieved at 45 minutes with concentration-matched controls. In addition, DehydraTECH-nicotine reached statistically significant peak blood plasma levels up to 10-fold higher overall than controls (p=0.004) while still clearing from blood virtually as quickly as the controls. “We are extremely pleased with the performance of our latest DehydraTECH-2.0 nicotine oral pouch formulations…

Continue Reading

TuesdayOct 05, 2021 10:37 am

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) to Present at LD Micro Conference

RYAH Group (CSE: RYAH) today announced that its CEO Gregory Wagner will be presenting at the virtual LD Micro conference on Tuesday, Oct. 12, 2021. The interactive online event is expected to give Wagner an opportunity to highlight RYAH's mission and approach for the audience of investment community professionals and existing shareholders. Wagner’s presentation is scheduled to begin at 10:30 a.m. ET, where he will elaborate on the company's recent developments and plans, and potentially open the floor for questions. Interested parties should visit https://cnw.fm/lsRUt to ensure access to the livestream conference and receive any updates. An archived webcast will…

Continue Reading

TuesdayOct 05, 2021 10:25 am

CannabisNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Naturo Group Announces Agreement with North America’s Leading Wholesale Distributor

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, is partnering with United Natural Foods Inc. (“UNFI”). According to the agreement, UNFI Canada will distribute BVNNF’s line of TRACE products across Canada. Calling the agreement a “significant milestone,” BevCanna noted that UNFI Canada is a subsidiary of UNFI, the largest publicly traded wholesale distributor in North America. UNFI has developed a reputation for delivering more than 275,000 products to retailers throughout Canada and the United States; UNFI’s network consists of more than 30,000 different customer locations. “This agreement with UNFI is…

Continue Reading

ThursdaySep 30, 2021 1:35 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Begins Phase 2 Clinical Trial Evaluating CBN in the EB Treatment

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has started its Phase 2 clinical trial of INM-755 (cannabinol) cream in the treatment of epidermolysis bullosa (“EB”). According to the company, this is the first time cannabinol has advanced to a Phase 2 clinical trial to be studied as a therapeutic option to treat a disease. The study will be conducted in seven different countries at 11 sites; the countries include Austria, Germany, Greece, France, Italy, Israel and Serbia. The company has filed clinical trial applications in all seven countries and has received approval from…

Continue Reading